Concepedia

Randolph S. Watnick

RS

Statistics

Publications

20

Citations

2.3K

H-Index

19

Active since

1998

Affiliations

Boston Children's Hospital(Current)

Harvard University

University of Bergen

Haukeland University Hospital

Brigham and Women's Hospital

Randolph S. Watnick is an author at Boston Children's Hospital specializing in medicine, oncology, and molecular oncology.

ORCID

Publications per year

1998–2024

20

Publications

20

Growth-Inhibitory and Tumor- Suppressive Functions of p53 Depend on Its Repression of CD44 Expression

Samuel Godár, Tan A. Ince, George W. Bell et al. · Cell · 2008 · 466 citations

, , +12

A Model of Human Tumor Dormancy: An Angiogenic Switch From the Nonangiogenic Phenotype

George N. Naumov, Elise R. Bender, David Zurakowski et al. · JNCI Journal of the National Cancer Institute · 2006 · 417 citations · Full text

, , +17

RETRACTED: Ras modulates Myc activity to repress thrombospondin-1 expression and increase tumor angiogenesis

Randolph S. Watnick, Yi-Ning Cheng, Annapoorni Rangarajan et al. · Cancer Cell · 2003 · 317 citations · Full text

, , +16

The Role of the Tumor Microenvironment in Regulating Angiogenesis

Randolph S. Watnick · Cold Spring Harbor Perspectives in Medicine · 2012 · 152 citations · Full text

, , +14

Reactive oxygen signaling and MAPK activation distinguish Epstein–Barr Virus (EBV)-positive versus EBV-negative Burkitt's lymphoma

Francesca Cerimele, Traci E. Battle, Rebecca M. Lynch et al. · Proceedings of the National Academy of Sciences · 2004 · 145 citations · Full text

, , +17

1–5 of 20